Most read article(s)

Article
Alemtuzumab long-term immunologic effectTreg suppressor function increases up to 24 months
Stefania De Mercanti, Simona Rolla, Angele Cucci, et al.

January 21, 2016
Research Article
Pure Relapsing Short MyelitisPart of the Multiple Sclerosis Spectrum or New Entity?
Zélia Poullet, Julie Pique, Adil Maarouf, et al.

April 26, 2022
Article
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
Jonathan Q. Tran, Jitesh Rana, Frederik Barkhof, et al.

August 27, 2014
Article
Thymoma and Autoimmune EncephalitisClinical Manifestations and Antibodies
Mar Guasp, Jon Landa, Eugenia Martinez-Hernandez, et al.

July 23, 2021
Article
Autoimmune Encephalitis Resembling Dementia Syndromes
Anna E.M. Bastiaansen, Robin W. van Steenhoven, Marienke A.A.M. de Bruijn, et al.

August 02, 2021
Article
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
Julia Pakpoor, Giulio Disanto, Daniel R. Altmann, et al.

October 01, 2015
Views & Reviews
Is MS affecting the CNS only?Lessons from clinic to myelin pathophysiology
Ellen Oudejans, Antonio Luchicchi, Eva M.M. Strijbis, et al.

November 24, 2020
Article
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders
Marius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, et al.

November 16, 2021
Article
Anti-IgLON5 DiseaseA New Bulbar-Onset Motor Neuron Mimic Syndrome
Jana Werner, Ilijas Jelcic, Esther Irene Schwarz, et al.

February 02, 2021
Views & Reviews
Autoimmune NeurologyThe Need for Comprehensive Care
Justin R. Abbatemarco, Stefanie J. Rodenbeck, Gregory S. Day, et al.

June 15, 2021

Pages